1. Alvarez-Nava, F., Soto, M., Lanes, R., et al. (2015). Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome. Journal of Obstetrics and Gynaecology Research, 41, 1891–1898.
2. American Academy of Pediatrics, & Committee on Genetics. (1995). Health supervision for children with Turner syndrome. Pediatrics, 96, 1166–1173.
3. Atton, G., Gordon, K., Brice, G., et al. (2015). The lymphatic phenotype in Turner syndrome: An evaluation of nineteen patients and literature review. European Journal of Human Genetics, 23, 1–6.
4. Bercu, B. B., Kramer, S. S., & Bode, H. H. (1976). A useful radiologic sign for the diagnosis of Turner’s syndrome. Pediatrics, 58, 737–739.
5. Binder, G., Schwarze, C. P., & Ranke, M. B. (2000). Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. Journal of Clinical Endocrinology and Metabolism, 85, 245–249.